This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
I. A. Scott, S. N. Hilmer, E. Reeve, K. Potter, D. Le Couteur, D. Rigby, D. Gnjidic, C. B. Del Mar, E. E. Roughead, A. Page, J. Jansen and J. H. Martin, Reducing inappropriate polypharmacy: the process of deprescribing, JAMA Intern. Med.175(5) (2015) 827–834; https://doi.org/10.1001/jamainternmed.2015.0324Search in Google Scholar
M. C. Woodward, Deprescribing: achieving better health outcomes for older people through reducing medications, J. Pharm. Pract. Res.33 (2003) 323–328; https://doi.org/10.1002/jppr2003334323Search in Google Scholar
E. Reeve, D. Gnjidic, J. Long and S. Hilmer, A systematic review of the emerging definition of ‘depre-scribing’ with network analysis: implications for future research and clinical practice, Br. J. Clin. Pharmacol.80(6) (2015) 1254–68; https://doi.org/10.1111/bcp.12732Search in Google Scholar
D. Gnjidic and E. Reeve, Deprescribing: What do we know, and where to next?, Br. J. Clin. Pharmacol.87(3) (2021) 722–724; https://doi.org/10.1111/bcp.14525Search in Google Scholar
T. A. Boghossian, F. J. Rashid, W. Thompson, V. Welch, P. Moayyedi, C. Rojas-Fernandez, K. Pottie and B. Farrell, Deprescribing versus continuation of chronic proton pump inhibitor use in adults, Cochrane Database Syst. Rev.3(3) (2017) CD011969; https://doi.org/10.1002/14651858.CD011969.pub2Search in Google Scholar
P. Haastrup, M. S. Paulsen, L. M. Begtrup, J. M. Hansen and D. E. Jarbøl, Strategies for discontinuation of proton pump inhibitors: a systematic review, Fam. Pract.31(6) (2014) 625–630; https://doi.org/10.1093/fampra/cmu050Search in Google Scholar
T. D. Wilsdon, I. Hendrix, T. R. Thynne and A. A. Mangoni, Effectiveness of interventions to depre-scribe inappropriate proton pump inhibitors in older adults, Drugs Aging34(4) (2017) 265–287; https://doi.org/10.1007/s40266-017-0442-1Search in Google Scholar
M. Gates, A. Gates, D. Pieper, R. M. Fernandes, A. C. Tricco, D. Moher, S. E. Brennan, T. Li, M. Pol-lock, C. Lunny, D. Sepúlveda, J. E. McKenzie, S. D. Scott, K. A. Robinson, K. Matthias, K. I. Bougioukas, P. Fusar-Poli, P. Whiting, S. J. Moss and L. Hartling, Reporting guideline for overviews of reviews of healthcare interventions: Development of the PRIOR statement, BMJ378 (2022) Article ID e070849 (13 pages); https://doi.org/10.1136/bmj-2022-070849Search in Google Scholar
M. J. Page, J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow, L. Shamseer, J. M. Tetzlaff, E. A. Akl, S. E. Brennan, R. Chou, J. Glanville, J. M. Grimshaw, A. Hróbjartsson, M. M. Lalu, T. Li, E. W. Loder, E. Mayo-Wilson, S. McDonald, L. A McGuinness, L. A Stewart, J. Thomas, A. C. Tricco, V. A. Welch, P. Whiting and D. Moher, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews, BMJ372 (2021) Article ID 71 (9 pages); https://doi.org/10.1136/bmj.n71Search in Google Scholar
A. Tong, K. Flemming, E. McInnes, S. Oliver and J. Craig, Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ, BMC Med. Res. Methodol.12(181) (2012); https://doi.org/10.1186/1471-2288-12-181Search in Google Scholar
S. Jongstra, J. K. Harrison, T. J. Quinn and E. Richard, Antihypertensive withdrawal for the prevention of cognitive decline, Cochrane Database Syst. Rev.11(11) (2016) Article ID CD011971 (49 pages); https://doi.org/10.1002/14651858.CD011971.pub2Search in Google Scholar
C. Parsons, W. Y. Lim, C. Loy, B. McGuinness, P. Passmore, S. A. Ward and C. Hughes, Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia, Cochrane Database Syst. Rev.2(2) (2021) Article ID CD009081 (77 pages); https://doi.org/10.1002/14651858.CD009081.pub2Search in Google Scholar
E. Reeve, M. Ong, A. Wu, J. Jansen, M. Petrovic and D. Gnjidic, A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people, Eur. J. Clin. Pharmacol.73(8) (2017) 927–935; https://doi.org/10.1007/s00228-017-2257-8Search in Google Scholar
A. M. S. Sørensen, S. Tarp, P. Johannsen, A. Lolk, E. Bandak, H. Pedersen, N. Saxtrup, H. Kallehauge, E. J. Solem and M. B. Christensen, Analgesics use and withdrawal in people with dementia – a register-based Danish study and a systematic review, Dan. Med. J.66(12) (2019) Article ID A5578 (6 pages).Search in Google Scholar
E. Van Leeuwen, M. Petrovic, M. L. van Driel, A. I. De Sutter, R. Vander Stichele, T. Declercq and T. Christiaens, Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia, Cochrane Database Syst. Rev.3(3) (2018) Article ID CD007726 (95 pages); https://doi.org/10.1002/14651858.CD007726.pub3Search in Google Scholar
A. M. Paquin, K. Zimmerman and J. L. Rudolph, Risk versus risk: a review of benzodiazepine reduction in older adults, Expert Opin. Drug Saf.13(7) (2014) 919–934; https://doi.org/10.1517/14740338.2014.925444Search in Google Scholar
J. Davies and J. Read, A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based?, Addict. Behav.97 (2019) 111–121; https://doi.org/10.1016/j.addbeh.2018.08.027Search in Google Scholar
K. Matsui, T. Tokumasu, Y. Takekita, K. Inada, T. Kanazawa, T. Kishimoto, S. Takasu, H. Tani, S. Tarutani, N. Hashimoto, H. Yamada, Y. Yamanouchi and H. Takeuchi, Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: a systematic review and meta-analysis, Schizophr. Res.209 (2019) 50–57; https://doi.org/10.1016/j.schres.2019.05.030Search in Google Scholar
E. Maund, B. Stuart, M. Moore, C. Dowrick, A. W. A. Geraghty, S. Dawson and T. Kendrick, Managing antidepressant discontinuation: a systematic review, Ann. Fam. Med.17(1) (2019) 52–60; https://doi.org/10.1370/afm.2336Search in Google Scholar
K. Monahan, J. Cuzens-Sutton, D. Siskind and S. Kisely, Quetiapine withdrawal: a systematic review, Aust. N. Z. J. Psychiatry55(8) (2021) 772–783; https://doi.org/10.1177/0004867420965693Search in Google Scholar
K. Mugunthan, T. McGuire and P. Glasziou, Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis, Br. J. Gen. Pract.61(590) (2011) e573–e578; https://doi.org/10.3399/bjgp11X593857Search in Google Scholar
J. M. Parr, D. J. Kavanagh, L. Cahill, G. Mitchell and R. McD Young, Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis, Addiction104(1) (2009) 13–24; https://doi.org/10.1111/j.1360-0443.2008.02364.xSearch in Google Scholar
P. R. S. Ribeiro and A. D. Schlindwein, Benzodiazepine deprescription strategies in chronic users: a systematic review, Fam. Pract. 38(5) (2021) 684–693; https://doi.org/10.1093/fampra/cmab017Search in Google Scholar
E. Van Leeuwen, M. L. van Driel, M. A. Horowitz, T. Kendrick, M. Donald, A. I. De Sutter, L. Robertson and T. Christiaens, Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults, Cochrane Database Syst. Rev.4(4) (2021) Article ID CD013495 (211 pages); https://doi.org/10.1002/14651858.CD013495.pub2Search in Google Scholar
C. D. Black, W. Thompson, V. Welch, L. McCarthy, C. Rojas-Fernandez, H. Lochnan, S. Shamji, R. Upshur and B. Farrell, Lack of evidence to guide deprescribing of antihyperglycemics: a systematic review, Diabetes Ther.8(1) (2017) 23–31; https://doi.org/10.1007/s13300-016-0220-9Search in Google Scholar
R. K. Boyapati, J. Torres, C. Palmela, C. E. Parker, O. M. Silverberg, S. D. Upadhyaya, T. M. Nguyen and J. F. Colombel, Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn’s disease, Cochrane Database Syst. Rev.5(5) (2018) Article ID CD012540 (43 pages); https://doi.org/10.1002/14651858.CD012540.pub2Search in Google Scholar
C. Eccleston, E. Fisher, K. H. Thomas, L. Hearn, S. Derry, C. Stannard, R. Knaggs and R. A. Moore, Interventions for the reduction of prescribed opioid use in chronic non-cancer pain, Cochrane Data‑ base Syst. Rev.11(11) (2017) CD010323; https://doi.org/10.1002/14651858.CD010323.pub3Search in Google Scholar
C. J. Edwards, B. Fautrel, H. Schulze-Koops, T. W. J. Huizinga and K. Kruger, Dosing down with biologic therapies: a systematic review and clinicians’ perspective, Rheumatology (Oxford), 56(11) (2017) 1847–1856; https://doi.org/10.1093/rheumatology/kew464Search in Google Scholar
I. Hopper, R. Samuel, C. Hayward, A. Tonkin and H. Krum, Can medications be safely withdrawn in patients with stable chronic heart failure? systematic review and meta-analysis, J. Card. Fail.20(7) (2014) 522–532; https://doi.org/10.1016/j.cardfail.2014.04.013Search in Google Scholar
M. Lamarre, M. Marcotte, D. Laurin, D. Furrer, I. Vedel, A. Tourigny, A. Giguère, P. H. Carmichael, R. Martines, J. Morais and E. Kröger, Discontinuation of bisphosphonates in seniors: a systematic review on health outcomes, Arch. Osteoporos.16(1) (2021) Article ID 133 (23 pages); https://doi.org/10.1007/s11657-021-01000-wSearch in Google Scholar
S. Mathieson, C. G. Maher, G. E. Ferreira, M. Hamilton, J. Jansen, A. J. McLachlan, M. Underwood and C. C. Lin, Deprescribing opioids in chronic non-cancer pain: systematic review of randomised trials, Drugs80(15) (2020) 1563–1576; https://doi.org/10.1007/s40265-020-01368-ySearch in Google Scholar
L. M Verhoef, B. J. van den Bemt, A. van der Maas, J. E. Vriezekolk, M. E. Hulscher, F. H. van den Hoogen, W. C. Jacobs, N. van Herwaarden and A. A. den Broeder, Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity, Cochrane Database Syst. Rev.5(5) (2019) Article ID CD010455 (96 pages); https://doi.org/10.1002/14651858.CD010455.pub3Search in Google Scholar
R. White, L. Bruggink, C. Hayes, A. Boyes and C. Paul, Feasibility of patient-focused behavioral interventions to support adults experiencing chronic noncancer pain during opioid tapering: a systematic literature review, Transl. Behav. Med.11(8) (2021) 1481–1494; https://doi.org/10.1093/tbm/ibab007Search in Google Scholar
A. Zorrilla-Vaca, G. E. Mena, P. T. Ramirez, B. H. Lee, A. Sideris and C. L. Wu, Effectiveness of peri-operative opioid educational initiatives: a systematic review and meta-analysis, Anesth. Analg.134(5) (2022) 940–951; https://doi.org/10.1213/ANE.0000000000005634Search in Google Scholar
W. D. Lohr, J. W. Wanta, M. Baker, E. Grudnikoff, W. Morgan, D. Chhabra and T. Lee, Intentional discontinuation of psychostimulants used to treat ADHD in youth: a review and analysis, Front. Psychiatry 12(2021) ) Article ID 642798 (14 pages); https://doi.org/10.3389/fpsyt.2021.642798Search in Google Scholar
G. H. van de Loo-Neus, N. Rommelse and J. K. Buitelaar, To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended?, Eur. Neuropsycho‑ pharmacol.21(8) (2011) 584–599; https://doi.org/10.1016/j.euroneuro.2011.03.008Search in Google Scholar
F. Ayuga Loro, E. Gisbert Tijeras and F. Brigo, Rapid versus slow withdrawal of antiepileptic drugs, Cochrane Database Syst. Rev. 1(1) (2022) Article ID CD005003 (32 pages); https://doi.org/10.1002/14651858.CD005003.pub4Search in Google Scholar
E. G. Dixon, C. King, A. Lilley, I. P. Sinha and D. B. Hawcutt, Deprescribing montelukast in children with asthma: a systematic review, BMJ Open12(1) (2022) Article ID e053112 (8 pages); https://doi.org/10.1136/bmjopen-2021-053112Search in Google Scholar
S. Iyer, V. Naganathan, A. J. McLachlan and D. G. Le Couteur, Medication withdrawal trials in people aged 65 years and older: a systematic review, Drugs Aging25(12) (2008) 1021–1031; https://doi.org/10.2165/0002512-200825120-00004Search in Google Scholar
S. W. Narayan and P. S. Nishtala, Discontinuation of preventive medicines in older people with limited life expectancy: a systematic review, Drugs Aging34(10) (2017) 767–776; https://doi.org/10.1007/s40266-017-0487-1Search in Google Scholar
S. Crisafulli, N. Luxi, R. Coppini, A. Capuano, C. Scavone, A. Zinzi, S. Vecchi, G. Onder, J. Sultana and G. Trifirò, Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials, BMC Fam. Pract.22(1) (2021) 208; https://doi.org/10.1186/s12875-021-01557-ySearch in Google Scholar
E. Reeve, V. Jordan, W. Thompson, M. Sawan, A. Todd, T. M. Gammie, I. Hopper, S. N. Hilmer and D. Gnjidic, Withdrawal of antihypertensive drugs in older people, Cochrane Database Syst. Rev.6(6) (2020) Article ID CD012572 (59 pages); https://doi.org/10.1002/14651858.CD012572.pub2Search in Google Scholar
C. Hernández-Prats, E. López-Pintor and B. Lumbreras, Pharmacist-led intervention on the reduction of inappropriate medication use in patients with heart failure: a systematic review of randomized trials and non-randomized intervention studies, Res. Social. Adm. Pharm.18(5) (2022) 2748–2756; https://doi.org/10.1016/j.sapharm.2021.06.023Search in Google Scholar
N. Arulkumaran, M. Khpal, K. Tam, A. Baheerathan, C. Corredor and M. Singer, Effect of anti biotic discontinuation strategies on mortality and infectious complications in critically ill septic patients: a meta-analysis and trial sequential analysis, Crit. Care Med.48(5) (2020) 757–764; https://doi.org/10.1097/CCM.0000000000004267Search in Google Scholar
R. S. Bourne, J. K. Jennings, M. Panagioti, A. Hodkinson, A. Sutton and D. M. Ashcroft, Medication--related interventions to improve medication safety and patient outcomes on transition from adult intensive care settings: a systematic review and meta-analysis, BMJ Qual. Saf.31(8) (2022) 609–622; https://doi.org/10.1136/bmjqs-2021-013760Search in Google Scholar
M. Cardona, P. Stehlik, P. Fawzy, O. Byambasuren, J. Anderson, J. Clark, S. Sun and I. Scott, Effectiveness and sustainability of deprescribing for hospitalized older patients near end of life: a systematic review, Expert Opin. Drug Saf.20(1) (2021) 81–91; https://doi.org/10.1080/14740338.2021.1853704Search in Google Scholar
S. W. Lam, S. R. Bauer, R. Fowler and A. Duggal, Systematic review and meta-analysis of procalcitonin-guidance versus usual care for antimicrobial management in critically ill patients: focus on subgroups based on antibiotic initiation, cessation, or mixed strategies, Crit. Care Med.46(5) (2018) 684–690; https://doi.org/10.1097/CCM.0000000000002953Search in Google Scholar
J. Lee, A. Negm, R. Peters, E. K. C. Wong and A. Holbrook, Deprescribing fall-risk increasing drugs (FRIDs) for the prevention of falls and fall-related complications: a systematic review and meta-analysis, BMJ Open11(2) (2021) Article ID e035978 (10 pages); https://doi.org/10.1136/bmjopen-2019-035978Search in Google Scholar
J. W. Lee, M. Li, C. M. Boyd, A. R. Green and S. L. Szanton, Preoperative deprescribing for medical optimization of older adults undergoing surgery: a systematic review, J. Am. Med. Dir. Assoc.23(4) (2022) 528–536.e2; https://doi.org/10.1016/j.jamda.2021.11.005Search in Google Scholar
D. Saeed, G. Carter and C. Parsons, Interventions to improve medicines optimisation in frail older patients in secondary and acute care settings: a systematic review of randomised controlled trials and non-randomised studies, Int. J. Clin. Pharm.44(1) (2022) 15–26; https://doi.org/10.1007/s11096-021-01354-8Search in Google Scholar
P. Schuetz, Y. Wirz, R. Sager, M. Christ-Crain, D. Stolz, M. Tamm, L. Bouadma, C. E. Luyt, M. Wolff, J. Chastre, F. Tubach, K. B. Kristoffersen, O. Burkhardt, T. Welte, S. Schroeder, V. Nobre, L. Wei, H. C. Bucher, N. Bhatnagar, D. Annane, K. Reinhart, A. Branche, P. Damas, M. Nijsten, D. W. de Lange, R. O. Deliberato, S. S. Lima, V. Maravić-Stojković, A. Verduri, B. Cao, Y. Shehabi, A. Beishuizen, J. S. Jensen, C. Corti, J. A. Van Oers, A. R. Falsey, E. de Jong, C. F. Oliveira, B. Beghe, M. Briel and B. Mueller, Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections, The Co‑ chrane Database Syst. Rev.10(10) (2017) Article ID CD007498 (104 pages); https://doi.org/10.1002/14651858.CD007498.pub3Search in Google Scholar
N. J. Soni, D. J. Samson, J. L. Galaydick, V. Vats, E. S. Huang, N. Aronson and D. L. Pitrak, Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis, J. Hosp. Med.8(9) (2013) 530–540; https://doi.org/10.1002/jhm.2067Search in Google Scholar
J. Thillainadesan, D. Gnjidic, S. Green and S. N. Hilmer, Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials, Drugs Aging35(4) (2018) 303–319; https://doi.org/10.1007/s40266-018-0536-4Search in Google Scholar
M. U. Ali, D. Sherifali, D. Fitzpatrick-Lewis, M. Kenny, A. Liu, L. Lamarche, D. Mangin and P. Raina, Polypharmacy and mobility outcomes, Mech. Aging Dev.192 (2020) Article ID 111356 (11 pages); https://doi.org/10.1016/j.mad.2020.111356Search in Google Scholar
H. E. Bloomfield, N. Greer, A. M. Linsky, J. Bolduc, T. Naidl, O. Vardeny, R. MacDonald, L. McKenzie and T. J. Wilt, Deprescribing for community-dwelling older adults: a systematic review and meta-analysis, J. Gen. Intern. Med.35(11) (2020) 3323–3332; https://doi.org/10.1007/s11606-020-06089-2Search in Google Scholar
I. Bužančić, I. Kummer, M. Držaić and M. Ortner Hadžiabdić, Community-based pharmacists’ role in deprescribing: a systematic review, Br. J. Clin. Pharmacol.88(2) (2022) 452–463; https://doi.org/10.1111/bcp.14947Search in Google Scholar
C. M. Christopher, K. C. Bhuvan, A. Blebil, D. Alex, M. I. M. Ibrahim, N. Ismail and A. A. Alrasheedy, Clinical and humanistic outcomes of community pharmacy-based healthcare interventions regarding medication use in older adults: a systematic review and meta-analysis, Healthcare9(11) (2021) Article ID 1577 (18 pages); https://doi.org/10.3390/healthcare9111577Search in Google Scholar
H. Dills, K. Shah, B. Messinger-Rapport, K. Bradford and Q. Syed, Deprescribing medications for chronic diseases management in primary care settings: a systematic review of randomized controlled trials, J. Am. Med. Dir. Assoc.19(11) (2018) 923–935.e2; https://doi.org/10.1016/j.jamda.2018.06.021Search in Google Scholar
S. Romano, D. Figueira, I. Teixeira and J. Perelman, Deprescribing interventions among community-dwelling older adults: a systematic review of economic evaluations, Pharmacoeconomics40(3) (2022) 269–295; https://doi.org/10.1007/s40273-021-01120-8Search in Google Scholar
S. L. Thio, J. Nam, M. L. van Driel, T. Dirven and J. W. Blom, Effects of discontinuation of chronic medication in primary care: a systematic review of deprescribing trials, Br. J. Gen. Pract.68(675) (2018) e663–e672; https://doi.org/10.3399/bjgp18X699041Search in Google Scholar
J. Ulley, D. Harrop, A. Ali, S. Alton and S. Fowler Davis, Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review, BMC Geriatr.19(1) (2019) Article ID 15 (13 pages); https://doi.org/10.1186/s12877-019-1031-4Search in Google Scholar
C. H. Kua, V. S. L. Mak and S. W. Huey Lee, Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis, J. Am. Med. Dir. Assoc.20(3) (2019) 362–372.e11; https://doi.org/10.1016/j.jamda.2018.10.026Search in Google Scholar
M. Steinman and E. Reeve, UpToDate: Deprescribing, April 2021; https://www.uptodate.com/contents/deprescribing?search=deprescribing&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#disclaimerContent; last access date September 1, 2022.Search in Google Scholar
A. T. Page, R. M. Clifford, K. Potter, D. Schwartz and C. D. Etherton-Beer, The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis, Br. J. Clin. Pharmacol.82(3) (2016) 583–623; https://doi.org/10.1111/bcp.12975Search in Google Scholar
R. Ostini, C. Jackson, D. Hegney and S. E. Tett, How is medication prescribing ceased? a systematic review, Med. Care49(1) (2011) 24–36; https://doi.org/10.1097/MLR.0b013e3181ef9a7eSearch in Google Scholar
S. Shrestha, A. Poudel, M. Cardona, K. J. Steadman and L. M. Nissen, Impact of deprescribing dual-purpose medications on patient-related outcomes for older adults near end-of-life: a systematic review and meta-analysis, Ther. Adv. Drug Saf.12 (2021) Article ID 20420986211052343 (16 pages); https://doi.org/10.1177/20420986211052343Search in Google Scholar
A. H. Abdelhafiz and A. J. Sinclair, Deintensification of hypoglycaemic medications-use of a s ystematic review approach to highlight safety concerns in older people with type 2 diabetes, J. Diabetes Complications32(4) (2018) 444–450; https://doi.org/10.1016/j.jdiacomp.2017.11.011Search in Google Scholar
J. A. Pruskowski, S. Springer, C. T. Thorpe, M. Klein-Fedyshin and S. M. Handler, Does deprescribing improve quality of life? A systematic review of the literature, Drugs Aging36(12) (2019) 1097–1110; https://doi.org/10.1007/s40266-019-00717-1Search in Google Scholar
J. W. Blom, C. Muth, P. Glasziou, J. P. McCormack, R. Perera, R. K. E. Poortvliet, M. E. Numans, P. Thürmann, U. Thiem, S. L. Thio, M. Van Driel, M. Beyer, M. Van den Akker and J. A. Knottnerus, Describing deprescribing trials better: an elaboration of the CONSORT statement, J. Clin. Epidemiol.127 (2020) 87–95; https://doi.org/10.1016/j.jclinepi.2020.07.011Search in Google Scholar
C. R. Hansen, D. O’Mahony, P. M. Kearney, L. J. Sahm, S. Cullinan, C. J. A. Huibers, S. Thevelin, A. W. S. Rutjes, W. Knol, S. Streit and S. Byrne, Identification of behaviour change techniques in depre-scribing interventions: a systematic review and meta-analysis, Br. J. Clin. Pharmacol.84(12) (2018) 2716–2728; https://doi.org/10.1111/bcp.13742Search in Google Scholar
L. Monteiro, T. Maricoto, I. Solha, I. Ribeiro-Vaz, C. Martins and M. Monteiro-Soares, Reducing potentially inappropriate prescriptions for older patients using computerized decision support tools: systematic review, J. Med. Internet Res.21(11) (2019) e15385; https://doi.org/10.2196/15385Search in Google Scholar
S. Shrestha, A. Poudel, K. Steadman and L. Nissen, Outcomes of deprescribing interventions in older patients with life-limiting illness and limited life expectancy: a systematic review, Br. J. Clin. Pharmacol.86(10) (2020) 1931–1945; https://doi.org/10.1111/bcp.14113Search in Google Scholar
S. Seidu, S. K. Kunutsor, P. Topsever, C. E. Hambling, F. X. Cos and K. Khunti, Deintensification in older patients with type 2 diabetes: a systematic review of approaches, rates and outcomes, Diabetes Obes. Metab.21(7) (2019) 1668–1679; https://doi.org/10.1111/dom.13724Search in Google Scholar
V. Beslon, P. Moreau, A. Maruani, H. Maisonneuve, B. Giraudeau and J. P. Fournier, Effects of discontinuation of urate-lowering therapy: a systematic review, J. Gen. Intern. Med.33(3) (2018) 358–366; https://doi.org/10.1007/s11606-017-4233-5Search in Google Scholar
Y. L. Chock, Y. L. Wee, S. L. Gan, K. W. Teoh, K. Y. Ng and S. W. H. Lee, How willing are patients or their caregivers to deprescribe: a systematic review and meta-analysis, J. Gen. Intern. Med.36(12) (2021) 3830–3840; https://doi.org/10.1007/s11606-021-06965-5Search in Google Scholar
K. R. Weir, N. J. Ailabouni, C. R. Schneider, S. N. Hilmer and E. Reeve, Consumer attitudes towards deprescribing: a systematic review and meta-analysis, J. Gerontol. A Biol. Sci. Med. Sci.77(5) (2022) 1020–1034; https://doi.org/10.1093/gerona/glab222Search in Google Scholar
M. P. Oktora, A. E. Edwina and P. Denig, Differences in older patients’ attitudes toward deprescribing at contextual and individual level, Front Public Health10 (2022) Article ID 795043 (7 pages); https://doi.org/10.3389/fpubh.2022.795043Search in Google Scholar
M. Seewoodharry, K. Khunti, M. J. Davies, C. Gillies and S. Seidu, Attitudes of older adults and their carers towards de-prescribing: a systematic review, Diabetes Med.39(7) (2022) Article ID e14801 (16 pages); https://doi.org/10.1111/dme.14801Search in Google Scholar
A. Burghle, C. Lundby, J. Ryg, J. Søndergaard, A. Pottegård, D. Nielsen and T. Graabæk, Attitudes towards deprescribing among older adults with limited life expectancy and their relatives: a systematic review, Drugs Aging37(7) (2020) 503–520; https://doi.org/10.1007/s40266-020-00774-xSearch in Google Scholar
A. J. Doherty, P. Boland, J. Reed, A. J. Clegg, A. M. Stephani, N. H. Williams, B. Shaw, L. Hedgecoe, R. Hill and L. Walker, Barriers and facilitators to deprescribing in primary care: a systematic review, BJGP Open4(3) (2020) Article ID bjgpopen20X101096 (14 pages); https://doi.org/10.3399/bjgpopen20X101096Search in Google Scholar
H. Bloomfield, A. Linsky, J. Bolduc, N. Greer, T. Naidl, O. Vardeny, R. MacDonald, L. McKenzie and T. J. Wilt, Deprescribing for older veterans: a systematic review, Department of Veterans Affairs (US) (2019).Search in Google Scholar
K. Paque, R. Vander Stichele, M. Elseviers, K. Pardon, T. Dilles, L. Deliens and T. Christiaens, Barriers and enablers to deprescribing in people with a life-limiting disease: a systematic review, Palliat. Med.33(1) (2019) 37–48; https://doi.org/10.1177/0269216318801124Search in Google Scholar
A. F. Rasmussen, S. S. Poulsen, L. I. K. Oldenburg and C. Vermehren, The barriers and facilitators of different stakeholders when deprescribing benzodiazepine receptor agonists in older patients-a systematic review, Metabolites11(4) (2021) Article ID 254 (12 pages); https://doi.org/10.3390/meta-bo11040254Search in Google Scholar
E. Reeve, J. To, I. Hendrix, S. Shakib, M. S. Roberts and M. D. Wiese, Patient barriers to and enablers of deprescribing: a systematic review, Drugs Aging30(10) (2013) 793–807; https://doi.org/10.1007/s40266-013-0106-8Search in Google Scholar
C. Stewart, K. Gallacher, A. Nakham, M. Cruickshank, R. Newlands, C. Bond, P. K. Myint, D. Bhattacharya and F. S. Mair, Barriers and facilitators to reducing anticholinergic burden: a qualitative systematic review, Int. J. Clin. Pharm.43(6) (2021) 1451–1460; https://doi.org/10.1007/s11096-021-01293-4Search in Google Scholar
G. Clarke, S. Johnston, P. Corrie, I. Kuhn and S. Barclay, Withdrawal of anticancer therapy in advanced disease: a systematic literature review, BMC Cancer15(2015) Article ID 892 (9 pages); https://doi.org/10.1186/s12885-015-1862-0Search in Google Scholar
E. Valdez-Martinez, J. Noyes and M. Bedolla, When to stop? Decision-making when children’s cancer treatment is no longer curative: a mixed-method systematic review, BMC Pediatr.14 (2014) Article ID 124 (25 pages); https://doi.org/10.1186/1471-2431-14-124Search in Google Scholar
C. Lundby, T. Graabaek, J. Ryg, J. Søndergaard, A. Pottegård and D. S. Nielsen, Health care professionals’ attitudes towards deprescribing in older patients with limited life expectancy: a systematic review, Br. J. Clin. Pharmacol.85(5) (2019) 868–892; https://doi.org/10.1111/bcp.13861Search in Google Scholar
K. Anderson, D. Stowasser, C. Freeman and I. Scott, Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis, BMJ Open4(12) (2014) Article ID e006544 (18 pages); https://doi.org/10.1136/bmjopen-2014-006544Search in Google Scholar
A. E. Moth, P. Hølmkjær, A. Holm, M. P. Rozing and G. Overbeck, What makes deprescription of psychotropic drugs in nursing home residents with dementia so challenging? a qualitative systematic review of barriers and facilitators, Drugs Aging38(8) (2021) 671–685; https://doi.org/10.1007/s40266-021-00875-1Search in Google Scholar
M. Michiels-Corsten, N. Gerlach, T. Schleef, U. Junius-Walker, N. Donner-Banzhoff and A. Viniol, Generic instruments for drug discontinuation in primary care: a systematic review, Br. J. Clin. Phar‑ macol.86(7) (2020) 1251–1266; https://doi.org/10.1111/bcp.14287Search in Google Scholar
W. Thompson, C. Lundby, T. Graabaek, D. S. Nielsen, J. Ryg, J. Søndergaard and A. Pottegård, Tools for Deprescribing in frail older persons and those with limited life expectancy: a systematic review, J. Am. Geriatr. Soc.67(1) (2019) 172–180; https://doi.org/10.1111/jgs.15616Search in Google Scholar
L. N. van Merendonk and M. Crul, Deprescribing in palliative patients with cancer: a concise review of tools and guidelines, Support Care Cancer30(4) (2022) 2933–2943; https://doi.org/10.1007/s00520-021-06605-ySearch in Google Scholar
B. N. Renn, A. A. Asghar-Ali, S. Thielke, A. Catic, S. R. Martini, B. G. Mitchell and M. E. Kunik, A systematic review of practice guidelines and recommendations for discontinuation of cholinesterase inhibitors in dementia, Am. J. Geriatr. Psychiatry26(2) (2018) 134–147; https://doi.org/10.1016/j.jagp.2017.09.027Search in Google Scholar
M. A. van der Ploeg, C. Floriani, W. P. Achterberg, J. M. K. Bogaerts, J. Gussekloo, S. P. Mooijaart, S. Streit, R. K. E. Poortvliet and Y. M. Drewes, Recommendations for (discontinuation of) statin treatment in older adults: review of guidelines, J. Am. Geriatr. Soc.68(2) (2020) 417–425; https://doi.org/10.1111/jgs.16219Search in Google Scholar
S. Darr-Foit, P. Elsner and J. Tittelbach, Deprescribing in dermatology: a systematic review of current dermatological guidelines, J. Dtsch. Dermatol. Ges.17(3) (2019) 261–265; https://doi.org/10.1111/ddg.13759Search in Google Scholar
M. A. Fajardo, K. R. Weir, C. Bonner, D. Gnjidic and J. Jansen, Availability and readability of patient education materials for deprescribing: an environmental scan, Br. J. Clin. Pharmacol.85(7) (2019) 1396–1406; https://doi.org/10.1111/bcp.13912Search in Google Scholar
A. J. Clough, S. N. Hilmer, S. L. Naismith, L. D. Kardell and D. Gnjidic, N-of-1 trials for assessing the effects of deprescribing medications on short-term clinical outcomes in older adults: a systematic review, J. Clin. Epidemiol.93 (2018) 112–119; https://doi.org/10.1016/j.jclinepi.2017.09.015Search in Google Scholar
T. Morel, J. Nguyen-Soenen, W. Thompson and J. Fournier, Development and validation of search filters to identify articles on deprescribing in Medline and Embase, BMC Med. Res. Methodol.22(79) (2022); https://doi.org/10.1186/s12874-022-01515-xSearch in Google Scholar
T. Johansson, M. E. Abuzahra, S. Keller, E. Mann, B. Faller, C. Sommerauer, J. Höck, C. Löffler, A. Köchling, J. Schuler, M. Flamm and A. Sönnichsen, Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis, Br. J. Clin. Pharmacol.82(2) (2016) 532–548; https://doi.org/10.1111/bcp.12959Search in Google Scholar
K. Ibrahim, N. J. Cox, J. M. Stevenson, S. Lim, S. D. S. Fraser and H. C. Roberts, A systematic review of the evidence for deprescribing interventions among older people living with frailty, BMC Geriatr.21(1) (2021) 258; https://doi.org/10.1186/s12877-021-02208-8Search in Google Scholar
M. S. Salahudeen, A. Alfahmi, A. Farooq, M. Akhtar, S. Ajaz, S. Alotaibi, M. Faiz and S. Ali, Effectiveness of interventions to improve the anticholinergic prescribing practice in older adults: a systematic review, J. Clin. Med.11(3) (2022) 714; https://doi.org/10.3390/jcm11030714102Search in Google Scholar
J. Lindsay, M. Dooley, J. Martin, M. Fay, A. Kearney and M. Barras, Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches, Support Care Cancer22(4) (2014) 1113–1119; https://doi.org/10.1007/s00520-013-2098-7Search in Google Scholar
A. Nakham, P. K. Myint, C. M. Bond, R. Newlands, Y. K. Loke and M. Cruickshank, Interventions to reduce anticholinergic burden in adults aged 65 and older: a systematic review, J. Am. Med. Dir. Assoc.21(2) (2020) 172–180.e5; https://doi.org/10.1016/j.jamda.2019.06.001Search in Google Scholar
